2021越南Vietbaby 600x600px

2021 Vietbaby Fair, welcome to join us!

We are pleased to announce that SunWay Biotech will exhibit at VIETBABY in Sai Gon Exhibition & Conference Center, Vietnam during 18-20 November this year! VIETBABY HCMC Exhibition: Vietbaby Fair | Vietnam Int’l Maternity – Baby & Kids Fair Time: 18 – 20/11/2021 Venue: Sai Gon Exhibition&Conference Center, SECC, 799 Nguyen Van Linh parkway, Dist 7, HCMC (here) Exhibition scale: 300 booths of 150 businesses Booth: C1-C6, HALL A1 We are looking forward to seeing you!

pharmaboardroom

White Paper-The Vigiis 101-LAB, provides bodywide microbiome benefits with just one ingredient

This white paper will expose the remaining untapped market potential for probiotics, as well as the role Vigiis® 101-LAB can play in meeting consumer needs for complete probiotic support across the microbiome.    •  USD $78.3 billion will be reached by global probiotics market in 2026    •   Constipation affecting 16% of US adults and 33% of US seniors   •  COVID-19 has rocketed sales of immune health supplements up 25 percent in 2020, with expected impact in probiotics.           

750x500

SunWay Biotech Presentation of 2021 BIO Asia-Taiwan (Online)

  We sincerely invite you to join us in the SunWay Biotech Presentation of BIO Asia-Taiwan. Please register for Free Admission to On-demand Company Presentations of BIO Asia-Taiwan during July 21-25. After registration, please click Session and then type cp31 or SunWay to join our Company Presentation and know more about our service. Register Now: https://bit.ly/3xFl57D  

貼紙兩張數位圖2

[Announcement] With an anti-counterfeiting label, it is recognized as a genuine product from SunWay Biotech!

It has come to our attention that some unscrupulous manufacturers and sellers have attempted to profit from the reputation and quality of SunWay’s brand by pedaling inferior counterfeit knock-offs. To ensure that you receive only genuine SunWay products, please ensure that there is an anti-counterfeiting label on your product since the beginning of this year. The anti-counterfeiting label is disposable and cannot be used again once it is torn. Consumer safety is SunWay’s highest concern, and we ask for your vigilance and assistance in identifying any counterfeit products. If you have any questions, please feel free to contact SunWay customer support. Customer Service: +886-2-2792-9568

FA260645-340B-46A0-90B9-156BB3EADFDC

Dr. Tzu-Ming Pan, head of technology of SunWay Biotech, was invited as speaker in 4th World Congress and Expo on Traditional and Alternative Medicine.

During 14-16 March 2021, 4th World Congress and Expo on Traditional and Alternative Medicine is organized in collaboration with Taipei Chinese Medical Association, Meridian World Health Organization Alliance (MWHOA), Chang Gung University, Tzu Chi University, I Shou University, and China Medical University. The Congress focused on the theme “World Health for everyone with local Wisdom and Resources,” with the domestic well-known speakers and international scholars were invited to publish the research of traditional and alternative medical therapies for global health issues through this online conference. The Head of Technology of SunWay Biotech, Dr. Tzu-Ming Pan, was invited as a speaker by Taipei Chinese Medical Association and Global Scientific Guild to announce at the conference that heart health supplement plays an important role for global health. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death globally. WHO says that about 17.9 million people worldwide died from CVDs in 2016 alone, representing 31 percent of all global deaths. Moreover, amid the COVID-19 crisis, the global market for Heart Healthy Ingredients estimated at US$16.6 Billion in the year 2020, is projected to reach a revised size of US$24.8 Billion by 2027, growing at a of 5.9% over the analysis period 2020-2027. Red yeast rice, as a dietary supplement ingredient for heart health, is prized for its ability to lower cholesterol […]

B3C40649-EEDF-4E9E-84A6-DD55DD649593-3

SunWay 2020 annual revenue was 314 million and will be listed on Taiwan Emerging Stock Market on January 18, 2021.

On January 12, SunWay Biotech Co., LTD. (1271) was invited by Fubon Securities Co., Ltd. to participate in the institutional investor conference. John Pan, President of SunWay Biotech, introduced two main ingredients-ANKASCIN 568-R and Vigiis 101-LAB probiotics and their application, and announced that SunWay Biotech will be listed on Taiwan Emerging Stock Market on January 18, 2021.

WeChat 圖片_20201202151515

Congratulations! The innovation of Professor Tzu-Ming Pan and SunWay Biotech is awarded “Advanced National Innovation Award” on 1 Dec 2020!

We, Innovators The innovation of Professor Tzu-Ming Pan and SunWay Biotech “The Red Yeast Rice- Improvement of Memory and Learning Abilities of Alzheimer’s Patients” was awarded the National Innovation Award in 2008. With the continuous innovation, specific research, and development process for promotion worldwide, this application has been twice awarded the “Advanced National Innovation Award” on 1 Dec 2020!   Advanced National Innovation Award Advanced National Innovation Award Advanced National Innovation Award Advanced National Innovation Award

consumerlab-review

ConsumerLab RYR Supplements Review: A different red yeast rice

A CL member asked about a newer type of red yeast rice known as ANKASCIN 568-R Plus. ConsumerLab added information about it to its Red Yeast Rice Review.   Ankascin 568-R Plus A very different type of red yeast rice product on the market is Ankascin 568-R Plus (Sunway Biotech Co., Ltd., Taiwan), which contains an extract of red yeast rice focusing on two compounds, ankaflavin and monascin, as opposed to the lovastatin compounds normally in red yeast rice products. It is a certified health food in Taiwan for regulating lipid function and to assist in regulating blood glucose function. It was accepted by the U.S. FDA as a new dietary ingredient in 2018 (which does not mean that it is effective, but that the FDA has not expressed safety concerns). An 8-week, placebo-controlled (but not double-blinded) study in Taiwan among 40 people with metabolic syndrome found no negative effects of Ankascin 568-Plus (500 mg daily) on liver, kidney, or thyroid function, nor any indication of muscle breakdown. There was no significant decrease in fasting blood glucose or triglyceride levels compared to placebo, but there was a 19% decrease in LDL cholesterol versus a 1.9% decrease with placebo. Although funding of the study was not disclosed, one of the study authors is employed by Sunway Biotch (Liu, J Food Drug Analysis 2018). It […]